Optimize Testing to Support the Global Hepatitis Elimination Initiative
April 30, 2025 - 15:00 BST / 16:00 CEST / 10:00 EDT / 07:00 PDT
The Coalition for Global Hepatitis Elimination (CGHE) is dedicated to accelerating the eradication of hepatitis B and C worldwide. Operating under the Task Force for Global Health, CGHE collaborates with various partners to enhance the capacity of national and sub-national elimination programs.
During this webinar, attendees will learn about the CGHE's objectives, plan, and updated status. Current challenges in testing, including accessibility and accuracy will also be examined.
Key learning objectives
- Identify key challenges and barriers in global hepatitis elimination efforts and explore strategies to overcome them
- Discuss the Coalition for Global Hepatitis Elimination (CGHE)—its mission, programs, and impact on advancing elimination goals
- Explain how improvements in laboratory workflow efficiencies in diagnostics play an essential role in initiatives such as hepatitis elimination
Who should attend?
Healthcare professionals, clinical staff, lab technicians, pathologists, lab directors, laboratorians, researchers, and academics
Accreditation statement
SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Speakers
Dr. Alan H.B. Wu is Chief of Clinical Chemistry and Toxicology at San Francisco General Hospital and Professor of Lab Medicine, University of California, San Francisco. He received BS degrees in chemistry and biology at Purdue University and a PhD degree in analytical chemistry at the University of Illinois. He completed a postdoctoral fellowship in clinical chemistry at Hartford Hospital. He is certified by the American Board of Clinical Chemistry in Clinical Chemistry and Toxicological Chemistry. His research interests include clinical toxicology, cardiac biomarkers, and point-of-care testing. Dr. Wu has over 500 publications in peer-reviewed journals.
Over a 40-year career, Dr. Ward’s work spans the practice of epidemiology, laboratory science, clinical trials, public health program practice, policy development, health communication, education, and clinical medicine in the prevention and control of HIV/AIDS and the elimination of viral hepatitis. He currently directs the Coalition for Global Hepatitis Elimination, operating under the Task Force for Global Health, providing a community of practice for hepatitis elimination programs to collaborate, receive technical assistance, and participate in operational research.
Moderator
